Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Covid19
- Sponsor
- Polish Mother Memorial Hospital Research Institute
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Prognosis in patients who have recovered from COVID-19
- Status
- Active, Not Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The subject of the study is the impact of COVID-19 on the indicators of myocardial efficiency and exercise capacity. As a result of the observed dependencies, it will be possible to start an appropriate diagnostic procedure early, select personalized treatment and develop a model of cardiological care for people with a history of SARS-CoV-2 infection and improve the quality and extend their life.
Detailed Description
About 100 adult patients hospitalized in the Department of Cardiology and Congenital Heart Diseases of Adults who had recovered from COVID-19 will be included in the study. Selected prognostic factors will be analyzed, among others: demographic data of the patient, physical examination, symptoms, co-morbidities, results of selected laboratory tests, lung imaging (X-ray or computed tomography) selected electrocardiographic and echocardiographic data, patient's cooperation with the doctor, treatment applied, parameters in the spiroergometric study, body mass analysis. One year after inclusion in the study, a control hospitalization will be performed. The same factors will be analyzed.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age equal to or older than 18 years
- •infection with the SARS-CoV-2 in past medical history
- •current hospitalization
Exclusion Criteria
- •severe hypertension;
- •unstable angina;
- •acute pulmonary embolism;
- •decompensated heart failure;
- •recent myocardial infarction;
- •unstable heart rhythm disturbances;
- •acute myocarditis or pericarditis;
- •active endocarditis;
- •advanced atrioventricular block;
- •diagnosis of cardiomyopathy (hypertrophic, dilated, restrictive, peripartum, arrhythmogenic)
Outcomes
Primary Outcomes
Prognosis in patients who have recovered from COVID-19
Time Frame: 12 months after inclusion in the study
A control hospitalization will be conducted with patients. The same prognostic factors will be analyzed: physical examination, symptoms, co-morbidities, treatment applied, results of selected laboratory tests, lung imaging (X-ray or computed tomography) selected electrocardiographic (ECG) and echocardiographic data, parameters in the spiroergometric study, body mass analysis.
Secondary Outcomes
- The imaging of pulmonary changes in patients who have recovered from COVID-19(12 months after inclusion in the study)
- Review of selected Holter ECG monitoring data in patients who have recovered from COVID-19(12 months after inclusion in the study)
- Review of selected laboratory tests in patients who have recovered from COVID-19(12 months after inclusion in the study)
- Review of parameters in the spiroergometric study in patients who have recovered from COVID-19(12 months after inclusion in the study)
- Body mass analysis in patients who have recovered from COVID-19(12 months after inclusion in the study)
- Review of selected echocardiographic data in patients who have recovered from COVID-19(12 months after inclusion in the study)